What is Somalogic Inc (SLGC) stock price today?

Somalogic Inc (SLGC) currently trades at $9.89 per share. The stock has a market capitalization of $396.23M and a P/E ratio of —x.

Is SLGC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Somalogic Inc has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Somalogic Inc's revenue and earnings?

Somalogic Inc has trailing twelve-month (TTM) revenue of $81.72M with profit margins of -159.50%. Earnings per share (EPS) is $-0.69.

Is SLGC stock overvalued or undervalued?

Based on our DCF model, Somalogic Inc's intrinsic value is $1.86, representing a margin of safety of -12.90%. The stock currently trades at a P/E of —x.

SLGC

Somalogic Inc

NASDAQ: SLGC · HEALTHCARE · HEALTH INFORMATION SERVICES

$9.89

+0.00% today

Updated 2026-05-04

Market cap

$396.23M

P/E ratio

—

P/S ratio

4.85x

EPS (TTM)

$-0.69

Dividend yield

—

52W range

$19 – $20

Volume

1.0M

Market cap

$396.23M

P/E ratio

—

P/S ratio

4.85x

EPS (TTM)

$-0.69

Dividend yield

—

52W range

$19 – $20

Volume

1.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.7

Growth

5.0

Quality

C+

2.0

Profitability

4.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →198 stocks currently score above 75

Price targets

Analyst target

$3.93

-60.26%

12-Month target

—

Intrinsic (DCF)

$1.86

Margin of safety

-12.90%

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -159.50%

- Negative free cash flow $-121.89M

- Revenue declining -47.10% QoQ

- 12.90% above intrinsic value

Key financials

Revenue Net Income Free Cash Flow

Metric	2020	2021	2022	2023	TTM
Revenue	$55.89M	$81.63M	$97.67M	$81.72M	$81.72M
Net income	$-71.35M	$-86.30M	$-109.16M	$-130.38M	$-130.38M
EPS	—	—	—	—	$-0.69
Free cash flow	$-29.50M	$-43.70M	$-105.88M	$-121.89M	$-121.89M
Profit margin	-127.67%	-105.73%	-111.77%	-159.54%	-159.50%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SLGC	$396.23M	29	4.7	2.0	4.7	5.0	-12.90%	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-39.75%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-23.88%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+42.04%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

Somalogic Inc trades at $9.89. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $81.72M. with profit margins at -159.50%. Our DCF model estimates intrinsic value at $1.86.

Frequently asked questions

What is Somalogic Inc's stock price?

Somalogic Inc (SLGC) trades at $9.89.

Is Somalogic Inc overvalued?

Smart Value Score 29/100 (Grade F, Strong Sell). DCF value $1.86.

What is the price target of Somalogic Inc (SLGC)?

The analyst target price is $3.93, representing -60.3% downside from the current price of $9.89.

What is the intrinsic value of Somalogic Inc (SLGC)?

Based on our DCF model, intrinsic value is $1.86, a -12.9% margin of safety versus $9.89.

What is Somalogic Inc's revenue?

TTM revenue is $81.72M.

Company info

SectorHEALTHCARE

IndustryHEALTH INFORMATION SERVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio4.85x

ROE-23.70%

Beta1.64

50D MA$2.43

200D MA$2.45

Shares out0.19B

Float0.15B

Short ratio—

Avg volume1.0M

Performance

1 week+0.15%

1 month+0.76%

3 months+371.19%

YTD+371.19%

1 year+371.19%

3 years—

5 years—

Compare

SLGC vs LLY →SLGC vs JNJ →SLGC vs ABBV →Stock screener →